Greater Cannabis Company (GCAN) Total Non-Current Liabilities (2016 - 2021)

Greater Cannabis Company (GCAN) recorded quarterly Total Non-Current Liabilities of $460651.0 in Q1 2021, up 4.11% quarter-over-quarter from $442467.0 in Q4 2020, and down 53.71% on a YoY basis from $995119.0 in Q1 2020.

Greater Cannabis Company (GCAN) Total Non-Current Liabilities (2016 - 2021) Analysis & Trends

Greater Cannabis Company's Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $460651.0 for Q1 2021.

  • In Q1 2021, Total Non-Current Liabilities fell 53.71% year-over-year to $460651.0; the TTM figure through Mar 2021 stood at $460651.0 (down 53.71% YoY), while the FY2020 annual figure was $442467.0, down 72.03% from the prior year.
  • Total Non-Current Liabilities was $460651.0 for Q1 2021 at Greater Cannabis Company, up from $442467.0 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.6 million in Q4 2019 to a low of -$205403.0 in Q4 2017.
  • Historically, Total Non-Current Liabilities has averaged $517437.2 across 5 years, with a median of $459956.0 in 2019.
  • The sharpest annual moves came in 2017 and 2018: Total Non-Current Liabilities sank 2437.31% in 2017, then jumped 394.54% in 2018.
  • A 5-year view of Total Non-Current Liabilities shows it stood at -$205403.0 in 2017, then jumped by 394.54% to $604999.0 in 2018, then jumped by 161.46% to $1.6 million in 2019, then plunged by 72.03% to $442467.0 in 2020, then gained by 4.11% to $460651.0 in 2021.
  • The last three Total Non-Current Liabilities figures came in at $460651.0 (Q1 2021), $442467.0 (Q4 2020), and $599261.0 (Q3 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 18.28 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 2.44 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.13 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 1.81 Bn
10 Greater Cannabis Company - - - -

Historic Data

Download Data
DateValue
Mar 31, 2021 460,651.00
Dec 31, 2020 442,467.00
Sep 30, 2020 599,261.00
Jun 30, 2020 774,453.00
Mar 31, 2020 995,119.00
Dec 31, 2019 1.58 Mn
Sep 30, 2019 508,947.00
Jun 30, 2019 459,956.00
Mar 31, 2019 409,882.00
Dec 31, 2018 604,999.00
Sep 30, 2018 401,874.00
Jun 30, 2018 274,624.00
Mar 31, 2018 217,776.00
Dec 31, 2017 -205,403.00
Sep 30, 2017 235,097.00
Dec 31, 2016 8,788.00